Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or With Dexamethasone in Relapsed and Refractory Multiple Myeloma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0469

Related search